Generic placeholder image

Current Topics in Medicinal Chemistry

Editor-in-Chief

ISSN (Print): 1568-0266
ISSN (Online): 1873-4294

Review Article

Hyaluronan-based Multifunctional Nano-carriers for Combination Cancer Therapy

Author(s): Menghan Gao, Hong Deng and Weiqi Zhang*

Volume 21, Issue 2, 2021

Published on: 22 September, 2020

Page: [126 - 139] Pages: 14

DOI: 10.2174/1568026620666200922113846

Price: $65

Abstract

Hyaluronan (HA) is a natural linear polysaccharide that has excellent hydrophilicity, biocompatibility, biodegradability, and low immunogenicity, making it one of the most attractive biopolymers used for biomedical researches and applications. Due to the multiple functional sites on HA and its intrinsic affinity for CD44, a receptor highly expressed on various cancer cells, HA has been widely engineered to construct different drug-loading nanoparticles (NPs) for CD44-targeted anti-tumor therapy. When a cocktail of drugs is co-loaded in HA NP, a multifunctional nano-carriers could be obtained, which features as a highly effective and self-targeting strategy to combat cancers with CD44 overexpression. The HA-based multidrug nano-carriers can be a combination of different drugs, various therapeutic modalities, or the integration of therapy and diagnostics (theranostics). Up to now, there are many types of HA-based multidrug nano-carriers constructed by different formulation strategies, including drug co-conjugates, micelles, nano-gels and hybrid NP of HA and so on. This multidrug nano-carrier takes the full advantages of HA as an NP matrix, drug carriers and targeting ligand, representing a simplified and biocompatible platform to realize the targeted and synergistic combination therapy against the cancers. In this review, recent progress of HA-based multidrug nano-carriers for combination cancer therapy is summarized and the potential challenges for translational applications have been discussed.

Keywords: Hyaluronan (HA), Combination cancer therapy, CD44, Drug delivery, Nano-carriers, Theranostics.

Graphical Abstract

[1]
Meacham, C.E.; Morrison, S.J. Tumour heterogeneity and cancer cell plasticity. Nature, 2013, 501(7467), 328-337.
[http://dx.doi.org/10.1038/nature12624] [PMID: 24048065]
[2]
Dagogo-Jack, I.; Shaw, A.T. Tumour heterogeneity and resistance to cancer therapies. Nat. Rev. Clin. Oncol., 2018, 15(2), 81-94.
[http://dx.doi.org/10.1038/nrclinonc.2017.166] [PMID: 29115304]
[3]
Vasan, N.; Baselga, J.; Hyman, D.M. A view on drug resistance in cancer. Nature, 2019, 575(7782), 299-309.
[http://dx.doi.org/10.1038/s41586-019-1730-1] [PMID: 31723286]
[4]
Mignani, S.; Bryszewska, M.; Klajnert-Maculewicz, B.; Zablocka, M.; Majoral, J.P. Advances in combination therapies based on nanoparticles for efficacious cancer treatment: an analytical report. Biomacromolecules, 2015, 16(1), 1-27.
[http://dx.doi.org/10.1021/bm501285t] [PMID: 25426779]
[5]
Zhang; Rui; Xue; Eoh; June; Young; Xue; Hui; Yi; Wong. Nanomedicine of synergistic drug combinations for cancer therapy - strategies and perspectives. J. Control. Release, 2016, 240, 489-503.
[6]
Tibbitt, M.W.; Dahlman, J.E.; Langer, R. Emerging frontiers in drug delivery. J. Am. Chem. Soc., 2016, 138(3), 704-717.
[http://dx.doi.org/10.1021/jacs.5b09974] [PMID: 26741786]
[7]
Min, Y.; Caster, J.M.; Eblan, M.J.; Wang, A.Z. Clinical translation of nanomedicine. Chem. Rev., 2015, 115(19), 11147-11190.
[http://dx.doi.org/10.1021/acs.chemrev.5b00116] [PMID: 26088284]
[8]
Matsumura, Y.; Maeda, H. A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs. Cancer Res., 1986, 46, 6387-6392.
[9]
Maeda, H.; Nakamura, H.; Fang, J. The EPR effect for macromolecular drug delivery to solid tumors: Improvement of tumor uptake, lowering of systemic toxicity, and distinct tumor imaging in vivo. Adv. Drug Deliv. Rev., 2013, 65(1), 71-79.
[http://dx.doi.org/10.1016/j.addr.2012.10.002] [PMID: 23088862]
[10]
Kobayashi, H.; Watanabe, R.; Choyke, P.L. Improving conventional enhanced permeability and retention (EPR) effects; what is the appropriate target? Theranostics, 2013, 4(1), 81-89.
[http://dx.doi.org/10.7150/thno.7193] [PMID: 24396516]
[11]
Kavanagh, O.N.; Albadarin, A.B.; Croker, D.M.; Healy, A.M.; Walker, G.M. Maximising success in multidrug formulation development: A review. J. Control. Release, 2018, 283, 1-19.
[http://dx.doi.org/10.1016/j.jconrel.2018.05.024] [PMID: 29802867]
[12]
Xu, X.; Ho, W.; Zhang, X.; Bertrand, N.; Farokhzad, O. Cancer nanomedicine: from targeted delivery to combination therapy. Trends Mol. Med., 2015, 21(4), 223-232.
[http://dx.doi.org/10.1016/j.molmed.2015.01.001] [PMID: 25656384]
[13]
Kim, H.; Park, Y.; Stevens, M.M.; Kwon, W.; Hahn, S.K. Multifunctional hyaluronate - nanoparticle hybrid systems for diagnostic, therapeutic and theranostic applications. J. Control. Release, 2019, 303, 55-66.
[http://dx.doi.org/10.1016/j.jconrel.2019.04.003] [PMID: 30954619]
[14]
Jeannot, V.; Gauche, C.; Mazzaferro, S.; Couvet, M.; Vanwonterghem, L.; Henry, M.; Didier, C.; Vollaire, J.; Josserand, V.; Coll, J.L.; Schatz, C.; Lecommandoux, S.; Hurbin, A. Anti-tumor efficacy of hyaluronan-based nanoparticles for the co-delivery of drugs in lung cancer. J. Control. Release, 2018, 275, 117-128.
[http://dx.doi.org/10.1016/j.jconrel.2018.02.024] [PMID: 29474960]
[15]
Eroglu, S.M.; Toksoy Oner, E.; Cansever Mutlu, E.; Sennaroglu Bostan, M. Sugar based biopolymers in nanomedicine; new emerging era for cancer imaging and therapy. Curr. Top. Med. Chem., 2017, 17(13), 1507-1520.
[http://dx.doi.org/10.2174/1568026616666161222101703]
[16]
Vasvani, S.; Kulkarni, P.; Rawtani, D. Hyaluronic acid: A review on its biology, aspects of drug delivery, route of administrations and a special emphasis on its approved marketed products and recent clinical studies. Int. J. Biol. Macromol., 2020, 151, 1012-1029.
[http://dx.doi.org/10.1016/j.ijbiomac.2019.11.066] [PMID: 31715233]
[17]
Stern, R. Hyaluronan catabolism: a new metabolic pathway. Eur. J. Cell Biol., 2004, 83(7), 317-325.
[http://dx.doi.org/10.1078/0171-9335-00392] [PMID: 15503855]
[18]
Dicker, K.T.; Gurski, L.A.; Pradhan-Bhatt, S.; Witt, R.L.; Farach-Carson, M.C.; Jia, X. Hyaluronan: a simple polysaccharide with diverse biological functions. Acta Biomater., 2014, 10(4), 1558-1570.
[http://dx.doi.org/10.1016/j.actbio.2013.12.019] [PMID: 24361428]
[19]
Kim, H.; Jeong, H.; Han, S.; Beack, S.; Hwang, B.W.; Shin, M.; Oh, S.S.; Hahn, S.K. Hyaluronate and its derivatives for customized biomedical applications. Biomaterials, 2017, 123, 155-171.
[http://dx.doi.org/10.1016/j.biomaterials.2017.01.029] [PMID: 28171824]
[20]
Caon, I.; Bartolini, B.; Parnigoni, A.; Caravà, E.; Moretto, P.; Viola, M.; Karousou, E.; Vigetti, D.; Passi, A. Revisiting the hallmarks of cancer: The role of hyaluronan. Semin. Cancer Biol., 2020, 62, 9-19.
[http://dx.doi.org/10.1016/j.semcancer.2019.07.007] [PMID: 31319162]
[21]
Skandalis, S.S.; Karalis, T.T.; Chatzopoulos, A.; Karamanos, N.K. Hyaluronan-CD44 axis orchestrates cancer stem cell functions. Cell. Signal., 2019, 63109377
[http://dx.doi.org/10.1016/j.cellsig.2019.109377] [PMID: 31362044]
[22]
Veiseh, M.; Turley, E.A. Hyaluronan metabolism in remodeling extracellular matrix: probes for imaging and therapy of breast cancer. Integr. Biol., 2011, 3(4), 304-315.
[http://dx.doi.org/10.1039/c0ib00096e] [PMID: 21264398]
[23]
Choi, K.Y.; Han, H.S.; Lee, E.S.; Shin, J.M.; Almquist, B.D.; Lee, D.S.; Park, J.H. Hyaluronic acid-based activatable nanomaterials for stimuli-responsive imaging and therapeutics: beyond cd44-mediated drug delivery. Adv. Mater., 2019, 31(34)e1803549
[http://dx.doi.org/10.1002/adma.201803549] [PMID: 30773699]
[24]
Dosio, F.; Arpicco, S.; Stella, B.; Fattal, E. Hyaluronic acid for anticancer drug and nucleic acid delivery. Adv. Drug Deliv. Rev., 2016, 97, 204-236.
[http://dx.doi.org/10.1016/j.addr.2015.11.011] [PMID: 26592477]
[25]
Poon, Z.; Lee, J.B.; Morton, S.W.; Hammond, P.T. Controlling in vivo stability and biodistribution in electrostatically assembled nanoparticles for systemic delivery. Nano Lett., 2011, 11(5), 2096-2103.
[http://dx.doi.org/10.1021/nl200636r] [PMID: 21524115]
[26]
Passi, A.; Vigetti, D. Hyaluronan as tunable drug delivery system. Adv. Drug Deliv. Rev., 2019, 146, 83-96.
[http://dx.doi.org/10.1016/j.addr.2019.08.006] [PMID: 31421148]
[27]
Sakurai, Y.; Harashima, H. Hyaluronan-modified nanoparticles for tumor-targeting. Expert Opin. Drug Deliv., 2019, 16(9), 915-936.
[http://dx.doi.org/10.1080/17425247.2019.1645115] [PMID: 31387408]
[28]
Vogus, D.R.; Evans, M.A.; Pusuluri, A.; Barajas, A.; Zhang, M.; Krishnan, V.; Nowak, M.; Menegatti, S.; Helgeson, M.E.; Squires, T.M.; Mitragotri, S. A hyaluronic acid conjugate engineered to synergistically and sequentially deliver gemcitabine and doxorubicin to treat triple negative breast cancer. J. Control. Release, 2017, 267, 191-202.
[http://dx.doi.org/10.1016/j.jconrel.2017.08.016] [PMID: 28823957]
[29]
Yao, J.; Zhang, L.; Zhou, J.; Liu, H.; Zhang, Q. Efficient simultaneous tumor targeting delivery of all-trans retinoid acid and Paclitaxel based on hyaluronic acid-based multifunctional nanocarrier. Mol. Pharm., 2013, 10(3), 1080-1091.
[http://dx.doi.org/10.1021/mp3005808] [PMID: 23320642]
[30]
Zhang, W.; Tung, C.H. Cisplatin cross-linked multifunctional nanodrugplexes for combination therapy. ACS Appl. Mater. Interfaces, 2017, 9(10), 8547-8555.
[http://dx.doi.org/10.1021/acsami.6b16500] [PMID: 28224786]
[31]
Noh, I.; Kim, H.O.; Choi, J.; Choi, Y.; Lee, D.K.; Huh, Y.M.; Haam, S. Co-delivery of paclitaxel and gemcitabine via CD44-targeting nanocarriers as a prodrug with synergistic antitumor activity against human biliary cancer. Biomaterials, 2015, 53, 763-774.
[http://dx.doi.org/10.1016/j.biomaterials.2015.03.006] [PMID: 25890771]
[32]
Zhu, Z.; Li, Y.; Yang, X.; Pan, W.; Pan, H. The reversion of anti-cancer drug antagonism of tamoxifen and docetaxel by the hyaluronic acid-decorated polymeric nanoparticles. Pharmacol. Res., 2017, 126, 84-96.
[http://dx.doi.org/10.1016/j.phrs.2017.07.011] [PMID: 28734999]
[33]
Ng, C.W.; Li, J.; Pu, K. Recent progresses in phototherapy-synergized cancer immunotherapy. Adv. Funct. Mater., 2018, 28(46), 1804.
[http://dx.doi.org/10.1002/adfm.201804688]
[34]
Li, S.; Sun, Z.; Deng, G.; Meng, X.; Li, W.; Ni, D.; Zhang, J.; Gong, P.; Cai, L. Dual-modal imaging-guided highly efficient photothermal therapy using heptamethine cyanine-conjugated hyaluronic acid micelles. Biomater. Sci., 2017, 5(6), 1122-1129.
[http://dx.doi.org/10.1039/C7BM00230K] [PMID: 28484754]
[35]
Chen, Y.; Li, H.; Deng, Y.; Sun, H.; Ke, X.; Ci, T. Near-infrared light triggered drug delivery system for higher efficacy of combined chemo-photothermal treatment. Acta Biomater., 2017, 51, 374-392.
[http://dx.doi.org/10.1016/j.actbio.2016.12.004] [PMID: 28088668]
[36]
Leroux, J.C. Editorial: Drug delivery: too much complexity, not enough reproducibility? Angew. Chem. Int. Ed. Engl., 2017, 56(48), 15170-15171.
[http://dx.doi.org/10.1002/anie.201709002] [PMID: 28967701]
[37]
The two directions of cancer nanomedicine. Nat. Nanotechnol., 2019, 14(12), 1083.
[http://dx.doi.org/10.1038/s41565-019-0597-5] [PMID: 31802029]
[38]
Camacho, K.M.; Kumar, S.; Menegatti, S.; Vogus, D.R.; Anselmo, A.C.; Mitragotri, S. Synergistic antitumor activity of camptothecin-doxorubicin combinations and their conjugates with hyaluronic acid. J. Control. Release, 2015, 210, 198-207.
[http://dx.doi.org/10.1016/j.jconrel.2015.04.031] [PMID: 25921087]
[39]
Wang, J.; Li, Y.; Wang, L.; Wang, X.; Tu, P. Comparison of hyaluronic acid-based micelles and polyethylene glycol-based micelles on reversal of multidrug resistance and enhanced anticancer efficacy in vitro and in vivo. Drug Deliv., 2018, 25(1), 330-340.
[http://dx.doi.org/10.1080/10717544.2018.1428385] [PMID: 29350064]
[40]
Hu, K.; Zhou, H.; Liu, Y.; Liu, Z.; Liu, J.; Tang, J.; Li, J.; Zhang, J.; Sheng, W.; Zhao, Y.; Wu, Y.; Chen, C. Hyaluronic acid functional amphipathic and redox-responsive polymer particles for the co-delivery of doxorubicin and cyclopamine to eradicate breast cancer cells and cancer stem cells. Nanoscale, 2015, 7(18), 8607-8618.
[http://dx.doi.org/10.1039/C5NR01084E] [PMID: 25898852]
[41]
Xu, Y.; Asghar, S.; Gao, S.; Chen, Z.; Huang, L.; Yin, L.; Ping, Q.; Xiao, Y. Polysaccharide-based nanoparticles for co-loading mitoxantrone and verapamil to overcome multidrug resistance in breast tumor. Int. J. Nanomedicine, 2017, 12, 7337-7350.
[http://dx.doi.org/10.2147/IJN.S145620] [PMID: 29066886]
[42]
Zhu, Y.; Wang, X.; Chen, J.; Zhang, J.; Meng, F.; Deng, C.; Cheng, R.; Feijen, J.; Zhong, Z. Bioresponsive and fluorescent hyaluronic acid-iodixanol nanogels for targeted X-ray computed tomographyimaging and chemotherapy of breast tumors. J. Control. Release, 2016, 244(Pt B), 229-239..
[http://dx.doi.org/10.1016/j.jconrel.2016.08.027] [PMID: 27568289]
[43]
Basu, A.; Kunduru, K.R.; Abtew, E.; Domb, A.J. Polysaccharide-based conjugates for biomedical applications. Bioconjug. Chem., 2015, 26(8), 1396-1412.
[http://dx.doi.org/10.1021/acs.bioconjchem.5b00242] [PMID: 26106905]
[44]
Li, Y.; Wang, Y.; Huang, G.; Gao, J. Cooperativity principles in self-assembled nanomedicine. Chem. Rev., 2018, 118(11), 5359-5391.
[http://dx.doi.org/10.1021/acs.chemrev.8b00195] [PMID: 29693377]
[45]
Yu, D.; Li, W.; Zhang, Y.; Zhang, B. Anti-tumor efficiency of paclitaxel and DNA when co-delivered by pH responsive ligand modified nanocarriers for breast cancer treatment. Biomed. Pharmacother., 2016, 83, 1428-1435.
[http://dx.doi.org/10.1016/j.biopha.2016.08.061] [PMID: 27592131]
[46]
Ma, W.; Guo, Q.; Li, Y.; Wang, X.; Wang, J.; Tu, P. Co-assembly of doxorubicin and curcumin targeted micelles for synergistic delivery and improving anti-tumor efficacy. Eur. J. Pharm. Biopharm., 2017, 112, 209-223.
[http://dx.doi.org/10.1016/j.ejpb.2016.11.033] [PMID: 27913127]
[47]
Yao, J.; Li, Y.; Sun, X.; Dahmani, F.Z.; Liu, H.; Zhou, J. Nanoparticle delivery and combination therapy of gambogic acid and all-trans retinoic acid. Int. J. Nanomedicine, 2014, 9, 3313-3324.
[http://dx.doi.org/10.2147/IJN.S62793] [PMID: 25045262]
[48]
Song, L.; Pan, Z.; Zhang, H.; Li, Y.; Zhang, Y.; Lin, J.; Su, G.; Ye, S.; Xie, L.; Li, Y.; Hou, Z. Dually folate/CD44 receptor-targeted self-assembled hyaluronic acid nanoparticles for dual-drug delivery and combination cancer therapy. J. Mater. Chem. B Mater. Biol. Med., 2017, 5(33), 6835-6846.
[http://dx.doi.org/10.1039/C7TB01548H] [PMID: 32264333]
[49]
Yun, D.; Kim, H.O.; Son, H.Y.; Choi, Y.; Noh, I.; Lim, J.W.; Kim, J.; Chun, H.; Park, G.; Lee, D.K.; Jang, S.I.; Jang, E.; Huh, Y.M.; Haam, S. Stent containing CD44-targeting polymeric prodrug nanoparticles that release paclitaxel and gemcitabine in a time interval-controlled manner for synergistic human biliary cancer therapy. J. Mater. Chem. B Mater. Biol. Med., 2017, 5(31), 6317-6324.
[http://dx.doi.org/10.1039/C7TB00356K] [PMID: 32264448]
[50]
Qiu, L.; Qiao, M.; Chen, Q.; Tian, C.; Long, M.; Wang, M.; Li, Z.; Hu, W.; Li, G.; Cheng, L.; Cheng, L.; Hu, H.; Zhao, X.; Chen, D. Enhanced effect of pH-sensitive mixed copolymer micelles for overcoming multidrug resistance of doxorubicin. Biomaterials, 2014, 35(37), 9877-9887.
[http://dx.doi.org/10.1016/j.biomaterials.2014.08.008] [PMID: 25201738]
[51]
Khunmanee, S.; Jeong, Y.; Park, H. Crosslinking method of hyaluronic-based hydrogel for biomedical applications. J. Tissue Eng., 2017, 82041731417726464
[http://dx.doi.org/10.1177/2041731417726464] [PMID: 28912946]
[52]
Zhang, W.; Zhang, Z.; Tung, C.H. Beyond chemotherapeutics: cisplatin as a temporary buckle to fabricate drug-loaded nanogels. Chem. Commun. (Camb.), 2017, 53(4), 779-782.
[http://dx.doi.org/10.1039/C6CC08230K] [PMID: 27999837]
[53]
Zhang, Y.; Wang, F.; Li, M.; Yu, Z.; Qi, R.; Ding, J.; Zhang, Z.; Chen, X. Self-stabilized hyaluronate nanogel for intracellular codelivery of doxorubicin and cisplatin to osteosarcoma. Adv. Sci., 2018, 5(5)1700821
[54]
Zhang, W.; Tung, C.H. Redox-responsive cisplatin nanogels for anticancer drug delivery. Chem. Commun. (Camb.), 2018, 54(60), 8367-8370.
[http://dx.doi.org/10.1039/C8CC01795F] [PMID: 29995047]
[55]
Zhang, R.; Ru, Y.; Gao, Y.; Li, J.; Mao, S. Layer-by-layer nanoparticles co-loading gemcitabine and platinum (IV) prodrugs for synergistic combination therapy of lung cancer. Drug Des. Devel. Ther., 2017, 11, 2631-2642.
[http://dx.doi.org/10.2147/DDDT.S143047] [PMID: 28919713]
[56]
Kim, K.S.; Kim, J.; Lee, J.Y.; Matsuda, S.; Hideshima, S.; Mori, Y.; Osaka, T.; Na, K. Stimuli-responsive magnetic nanoparticles for tumor-targeted bimodal imaging and photodynamic/hyperthermia combination therapy. Nanoscale, 2016, 8(22), 11625-11634.
[http://dx.doi.org/10.1039/C6NR02273A] [PMID: 27217004]
[57]
Zheng, S.; Han, J.; Jin, Z.; Kim, C.S.; Park, S.; Kim, K.P.; Park, J.O.; Choi, E. Dual tumor-targeted multifunctional magnetic hyaluronic acid micelles for enhanced MR imaging and combined photothermal-chemotherapy. Colloids Surf. B Biointerfaces, 2018, 164, 424-435.
[http://dx.doi.org/10.1016/j.colsurfb.2018.02.005] [PMID: 29433060]
[58]
Camacho, K.M.; Menegatti, S.; Mitragotri, S. Low-molecular-weight polymer-drug conjugates for synergistic anticancer activity of camptothecin and doxorubicin combinations. Nanomedicine (Lond.), 2016, 11(9), 1139-1151.
[http://dx.doi.org/10.2217/nnm.16.33] [PMID: 27079141]
[59]
Wang, L.; Zhang, H.; Qin, A.; Jin, Q.; Tang, B.Z.; Ji, J. Theranostic hyaluronic acid prodrug micelles with aggregation-induced emission characteristics for targeted drug delivery. Sci. China Chem., 2016, 59, 1609-1615.
[http://dx.doi.org/10.1007/s11426-016-0246-9]
[60]
Chen, D.; Wang, G.; Song, W.; Zhang, Q. Novel cd44 receptor targeting multifunctional “nano-eggs” based on double ph-sensitive nanoparticles for co-delivery of curcumin and paclitaxel to cancer cells and cancer stem cells. J. Nanopart. Res., 2015, 17, 1-10.
[http://dx.doi.org/10.1007/s11051-015-3217-9]
[61]
Chang, J.E.; Cho, H.J.; Yi, E.; Kim, D.D.; Jheon, S. Hypocrellin B and paclitaxel-encapsulated hyaluronic acid-ceramide nanoparticles for targeted photodynamic therapy in lung cancer. J. Photochem. Photobiol. B, 2016, 158, 113-121.
[http://dx.doi.org/10.1016/j.jphotobiol.2016.02.035] [PMID: 26967521]
[62]
Cho, H.J.; Yoon, H.Y.; Koo, H.; Ko, S.H.; Shim, J.S.; Lee, J.H.; Kim, K.; Kwon, I.C.; Kim, D.D. Self-assembled nanoparticles based on hyaluronic acid-ceramide (HA-CE) and Pluronic® for tumor-targeted delivery of docetaxel. Biomaterials, 2011, 32(29), 7181-7190.
[http://dx.doi.org/10.1016/j.biomaterials.2011.06.028] [PMID: 21733572]
[63]
Zhang, H.; Li, W.; Guo, X.; Kong, F.; Wang, Z.; Zhu, C.; Luo, L.; Li, Q.; Yang, J.; Du, Y.; You, J. Specifically increased paclitaxel release in tumor and synergetic therapy by a hyaluronic acid-tocopherol nanomicelle. ACS Appl. Mater. Interfaces, 2017, 9(24), 20385-20398.
[http://dx.doi.org/10.1021/acsami.7b02606] [PMID: 28540720]
[64]
Bae, K.H.; Tan, S.; Yamashita, A.; Ang, W.X.; Gao, S.J.; Wang, S.; Chung, J.E.; Kurisawa, M. Hyaluronic acid-green tea catechin micellar nanocomplexes: Fail-safe cisplatin nanomedicine for the treatment of ovarian cancer without off-target toxicity. Biomaterials, 2017, 148, 41-53.
[http://dx.doi.org/10.1016/j.biomaterials.2017.09.027] [PMID: 28961534]
[65]
Xia, J.; Du, Y.; Huang, L.; Chaurasiya, B.; Tu, J.; Webster, T.J.; Sun, C. Redox-responsive micelles from disulfide bond-bridged hyaluronic acid-tocopherol succinate for the treatment of melanoma. Nanomedicine (Lond.), 2018, 14(3), 713-723.
[http://dx.doi.org/10.1016/j.nano.2017.12.017] [PMID: 29317344]
[66]
Wang, H.; Sun, G.; Zhang, Z.; Ou, Y. Transcription activator, hyaluronic acid and tocopheryl succinate multi-functionalized novel lipid carriers encapsulating etoposide for lymphoma therapy. Biomed. Pharmacother., 2017, 91, 241-250.
[http://dx.doi.org/10.1016/j.biopha.2017.04.104] [PMID: 28460227]
[67]
Wang, J.; Ma, W.; Guo, Q.; Li, Y.; Hu, Z.; Zhu, Z.; Wang, X.; Zhao, Y.; Chai, X.; Tu, P. The effect of dual-functional hyaluronic acid-vitamin E succinate micelles on targeting delivery of doxorubicin. Int. J. Nanomedicine, 2016, 11, 5851-5870.
[http://dx.doi.org/10.2147/IJN.S113882] [PMID: 27853369]
[68]
Liang, D.S.; Su, H.T.; Liu, Y.J.; Wang, A.T.; Qi, X.R. Tumor-specific penetrating peptides-functionalized hyaluronic acid-d-α-tocopheryl succinate based nanoparticles for multi-task delivery to invasive cancers. Biomaterials, 2015, 71, 11-23.
[http://dx.doi.org/10.1016/j.biomaterials.2015.08.035] [PMID: 26310359]
[69]
Liang, D.; Wang, A.T.; Yang, Z.Z.; Liu, Y.J.; Qi, X.R. Enhance Cancer Cell Recognition and Overcome Drug Resistance Using Hyaluronic Acid and α-Tocopheryl Succinate Based Multifunctional Nanoparticles. Mol. Pharm., 2015, 12(6), 2189-2202.
[http://dx.doi.org/10.1021/acs.molpharmaceut.5b00129] [PMID: 25945733]
[70]
Zhang, L.; Yao, J.; Zhou, J.; Wang, T.; Zhang, Q. Glycyrrhetinic acid-graft-hyaluronic acid conjugate as a carrier for synergistic targeted delivery of antitumor drugs. Int. J. Pharm., 2013, 441(1-2), 654-664.
[http://dx.doi.org/10.1016/j.ijpharm.2012.10.030] [PMID: 23117024]
[71]
Debele, T.A.; Yu, L.Y.; Yang, C.S.; Shen, Y.A.; Lo, C.L. pH- and gsh-sensitive hyaluronic acid-mp conjugate micelles for intracellular delivery of doxorubicin to colon cancer cells and cancer stem cells. Biomacromolecules, 2018, 19(9), 3725-3737.
[http://dx.doi.org/10.1021/acs.biomac.8b00856] [PMID: 30044910]
[72]
Wang, W.; Xi, M.; Duan, X.; Wang, Y.; Kong, F. Delivery of baicalein and paclitaxel using self-assembled nanoparticles: synergistic antitumor effect in vitro and in vivo. Int. J. Nanomedicine, 2015, 10, 3737-3750.
[PMID: 26045664]
[73]
Abbad, S.; Wang, C.; Waddad, A.Y.; Lv, H.; Zhou, J. Preparation, in vitro and in vivo evaluation of polymeric nanoparticles based on hyaluronic acid-poly(butyl cyanoacrylate) and D-alpha-tocopheryl polyethylene glycol 1000 succinate for tumor-targeted delivery of morin hydrate. Int. J. Nanomedicine, 2015, 10, 305-320.
[PMID: 25609946]
[74]
Du, X.; Yin, S.; Zhou, F.; Du, X.; Xu, J.; Gu, X.; Wang, G.; Li, J. Reduction-sensitive mixed micelles for selective intracellular drug delivery to tumor cells and reversal of multidrug resistance. Int. J. Pharm., 2018, 550(1-2), 1-13.
[http://dx.doi.org/10.1016/j.ijpharm.2018.08.019] [PMID: 30114451]
[75]
Zhu, Q.; Chen, X.; Xu, X.; Zhang, Y.; Zhang, C.; Mo, R. Tumor-specific self-degradable nanogels as potential carriers for systemic delivery of anticancer proteins. Adv. Funct. Mater., 2018, 28, 1-10.
[http://dx.doi.org/10.1002/adfm.201707371]
[76]
Mitra, K.; Samsó, M.; Lyons, C.E.; Hartman, M.C.T. Hyaluronic acid grafted nanoparticles of a platinum(ii)-silicon(iv) phthalocyanine conjugate for tumor and mitochondria-targeted photodynamic therapy in red light. J. Mater. Chem. B Mater. Biol. Med., 2018, 6(45), 7373-7377.
[http://dx.doi.org/10.1039/C8TB02533A] [PMID: 31372221]
[77]
Zhang, W.; Tung, C.H. Real-Time visualization of lysosome destruction using a photosensitive toluidine blue nanogel. Chemistry, 2018, 24(9), 2089-2093.
[http://dx.doi.org/10.1002/chem.201705697] [PMID: 29314346]
[78]
Zhang, W.; Tung, C.H. Lysosome enlargement enhanced photochemotherapy using a multifunctional nanogel. ACS Appl. Mater. Interfaces, 2018, 10(5), 4343-4348.
[http://dx.doi.org/10.1021/acsami.7b16575] [PMID: 29356498]
[79]
Mi, F.L.; Wang, L.F.; Chu, P.Y.; Peng, S.L.; Feng, C.L.; Lai, Y.J.; Li, J.N.; Lin, Y.H. Active tumor-targeted co-delivery of epigallocatechin gallate and doxorubicin in nanoparticles for combination gastric cancer therapy. ACS Biomater. Sci. Eng., 2018, 4, 2847-2859.
[http://dx.doi.org/10.1021/acsbiomaterials.8b00242]
[80]
Xiong, H.; Ni, J.; Jiang, Z.; Tian, F.; Zhou, J.; Yao, J. Intracellular self-disassemble polysaccharide nanoassembly for multi-factors tumor drug resistance modulation of doxorubicin. Biomater. Sci., 2018, 6(9), 2527-2540.
[http://dx.doi.org/10.1039/C8BM00570B] [PMID: 30105340]
[81]
Wang, G.; Gao, S.; Tian, R.; Miller-Kleinhenz, J.; Qin, Z.; Liu, T.; Li, L.; Zhang, F.; Ma, Q.; Zhu, L. Theranostic Hyaluronic acid-iron micellar nanoparticles for magnetic-field-enhanced in vivo cancer chemotherapy. ChemMedChem, 2018, 13(1), 78-86.
[http://dx.doi.org/10.1002/cmdc.201700515] [PMID: 29086481]
[82]
Gao, S.; Wang, G.; Qin, Z.; Wang, X.; Zhao, G.; Ma, Q.; Zhu, L. Oxygen-generating hybrid nanoparticles to enhance fluorescent/photoacoustic/ultrasound imaging guided tumor photodynamic therapy. Biomaterials, 2017, 112, 324-335.
[http://dx.doi.org/10.1016/j.biomaterials.2016.10.030] [PMID: 27776285]
[83]
Kang, S.H.; Nafiujjaman, M.; Nurunnabi, M.; Li, L.; Khan, H.A.; Cho, K.J.; Huh, K.M.; Lee, Y. kyu. Hybrid photoactive nanomaterial composed of gold nanoparticles, pheophorbide-a and hyaluronic acid as a targeted bimodal phototherapy. Macromol. Res., 2015, 23, 474-484.
[http://dx.doi.org/10.1007/s13233-015-3061-x]
[84]
Gao, N.; Yang, W.; Nie, H.; Gong, Y.; Jing, J.; Gao, L.; Zhang, X. Turn-on theranostic fluorescent nanoprobe by electrostatic self-assembly of carbon dots with doxorubicin for targeted cancer cell imaging, in vivo hyaluronidase analysis, and targeted drug delivery. Biosens. Bioelectron., 2017, 96, 300-307.
[http://dx.doi.org/10.1016/j.bios.2017.05.019] [PMID: 28511113]
[85]
Jia, X.; Han, Y.; Pei, M.; Zhao, X.; Tian, K.; Zhou, T.; Liu, P. Multi-functionalized hyaluronic acid nanogels crosslinked with carbon dots as dual receptor-mediated targeting tumor theranostics. Carbohydr. Polym., 2016, 152, 391-397.
[http://dx.doi.org/10.1016/j.carbpol.2016.06.109] [PMID: 27516286]
[86]
Wang, G.; Zhang, F.; Tian, R.; Zhang, L.; Fu, G.; Yang, L.; Zhu, L. Nanotubes-embedded indocyanine green-hyaluronic acid nanoparticles for photoacoustic-imaging-guided phototherapy. ACS Appl. Mater. Interfaces, 2016, 8(8), 5608-5617.
[http://dx.doi.org/10.1021/acsami.5b12400] [PMID: 26860184]
[87]
Deng, L.; Wang, G.; Ren, J.; Zhang, B.; Yan, J.; Li, W.; Khashab, N.M. Enzymatically triggered multifunctional delivery system based on hyaluronic acid micelles. RSC Advances, 2012, 2, 12909-12914.
[http://dx.doi.org/10.1039/c2ra21888g]
[88]
Cho, H.J.; Yoon, H.Y.; Koo, H.; Ko, S.H.; Shim, J.S.; Cho, J.H.; Park, J.H.; Kim, K.; Kwon, I.C.; Kim, D.D. Hyaluronic acid-ceramide-based optical/MR dual imaging nanoprobe for cancer diagnosis. J. Control. Release, 2012, 162(1), 111-118.
[http://dx.doi.org/10.1016/j.jconrel.2012.06.011] [PMID: 22709587]
[89]
Bhattacharya, D.; Svechkarev, D.; Souchek, J.J.; Hill, T.K.; Taylor, M.A.; Natarajan, A.; Mohs, A.M. Impact of structurally modifying hyaluronic acid on CD44 interaction. J. Mater. Chem. B Mater. Biol. Med., 2017, 5(41), 8183-8192.
[http://dx.doi.org/10.1039/C7TB01895A] [PMID: 29354263]
[90]
Liang, K.; Ng, S.; Lee, F.; Lim, J.; Chung, J.E.; Lee, S.S.; Kurisawa, M. Targeted intracellular protein delivery based on hyaluronic acid-green tea catechin nanogels. Acta Biomater., 2016, 33, 142-152.
[http://dx.doi.org/10.1016/j.actbio.2016.01.011] [PMID: 26785145]
[91]
Gibbs, P.; Brown, T.J.; Ng, R.; Jennens, R.; Cinc, E.; Pho, M.; Michael, M.; Fox, R.M. A pilot human evaluation of a formulation of irinotecan and hyaluronic acid in 5-fluorouracil-refractory metastatic colorectal cancer patients. Chemotherapy, 2009, 55(1), 49-59.
[http://dx.doi.org/10.1159/000180339] [PMID: 19060478]
[92]
Alamgeer, M.; Neil Watkins, D.; Banakh, I.; Kumar, B.; Gough, D.J.; Markman, B.; Ganju, V. A phase IIa study of HA-irinotecan, formulation of hyaluronic acid and irinotecan targeting CD44 in extensive-stage small cell lung cancer. Invest. New Drugs, 2018, 36(2), 288-298.
[http://dx.doi.org/10.1007/s10637-017-0555-8] [PMID: 29277856]
[93]
Huang, G.; Huang, H. Application of hyaluronic acid as carriers in drug delivery. Drug Deliv., 2018, 25(1), 766-772.
[http://dx.doi.org/10.1080/10717544.2018.1450910] [PMID: 29536778]
[94]
Kwon, M.Y.; Wang, C.; Galarraga, J.H.; Puré, E.; Han, L.; Burdick, J.A. Influence of hyaluronic acid modification on CD44 binding towards the design of hydrogel biomaterials. Biomaterials, 2019, 222119451
[http://dx.doi.org/10.1016/j.biomaterials.2019.119451] [PMID: 31480001]
[95]
Bisso, S.; Leroux, J-C. Nanopharmaceuticals: A focus on their clinical translatability. Int. J. Pharm., 2020, 578119098
[http://dx.doi.org/10.1016/j.ijpharm.2020.119098] [PMID: 32018018]
[96]
Varkouhi, A.K.; Scholte, M.; Storm, G.; Haisma, H.J. Endosomal escape pathways for delivery of biologicals. J. Control. Release, 2011, 151(3), 220-228.
[http://dx.doi.org/10.1016/j.jconrel.2010.11.004] [PMID: 21078351]

Rights & Permissions Print Cite
© 2025 Bentham Science Publishers | Privacy Policy
Request history8.2.27PHP Version398msRequest Duration28MBMemory UsageGET article/{article_id}/{param?}Route
  • warninglog[20:43:50] LOG.warning: Optional parameter $article_id declared before required parameter $request i...
  • warninglog[20:43:51] LOG.warning: Function strftime() is deprecated in /home/alphaeurekaselec/public_html/stor...
  • warninglog[20:43:51] LOG.warning: trim(): Passing null to parameter #1 ($string) of type string is deprecated ...
  • warninglog[20:43:51] LOG.warning: Function strftime() is deprecated in /home/alphaeurekaselec/public_html/stor...
  • Booting (92.08ms)time
  • Application (306ms)time
  • 1 x Application (76.89%)
    306ms
    1 x Booting (23.11%)
    92.08ms
    14 templates were rendered
    • articlearticle.blade.php#?blade
    • includes.article_top_bannerarticle_top_banner.blade.php#?blade
    • includes.article_referencearticle_reference.blade.php#?blade
    • export_citation_formexport_citation_form.blade.php#?blade
    • includes.article_bottom_bannerarticle_bottom_banner.blade.php#?blade
    • includes.inc_related_journalsinc_related_journals.blade.php#?blade
    • includes.inc_related_ebooksinc_related_ebooks.blade.php#?blade
    • includes.journal_rightmenujournal_rightmenu.blade.php#?blade
    • includes.journal_right_bannerjournal_right_banner.blade.php#?blade
    • layouts.appapp.blade.php#?blade
    • layouts._login_access_login_access.blade.php#?blade
    • layouts._header_header.blade.php#?blade
    • layouts._main_menu_main_menu.blade.php#?blade
    • layouts._footer_menu_footer_menu.blade.php#?blade
    uri
    GET article/{article_id}/{param?}
    middleware
    web, check_user_access
    controller
    App\Http\Controllers\ArticleController@GetArticleDetails
    namespace
    App\Http\Controllers
    where
    as
    article
    file
    app/Http/Controllers/ArticleController.php:1974-2510
    36 statements were executed, 4 of which were duplicates, 32 unique. Show only duplicated236ms
    • Connection Establishedalphaeurekaselec_live_10_06_2022UserAccessCheck.php#24
      Backtrace
      • 9. middleware::check_user_access:24
      • 10. vendor/laravel/framework/src/Illuminate/Pipeline/Pipeline.php:183
      • 11. vendor/laravel/framework/src/Illuminate/Routing/Middleware/SubstituteBindings.php:50
      • 12. vendor/laravel/framework/src/Illuminate/Pipeline/Pipeline.php:183
      • 13. vendor/laravel/framework/src/Illuminate/Foundation/Http/Middleware/VerifyCsrfToken.php:88
    • INSERT INTO visitor_ip_address (ip_address,visitor_agent,visitor_count, created_on,updated_on) VALUES ('873336012','',1,1740516230,1740516230) ON DUPLICATE KEY UPDATE visitor_count=visitor_count + 1, updated_on=1740516230
      930μsalphaeurekaselec_live_10_06_2022UserAccessCheck.php#24
      Backtrace
      • 11. middleware::check_user_access:24
      • 12. vendor/laravel/framework/src/Illuminate/Pipeline/Pipeline.php:183
      • 13. vendor/laravel/framework/src/Illuminate/Routing/Middleware/SubstituteBindings.php:50
      • 14. vendor/laravel/framework/src/Illuminate/Pipeline/Pipeline.php:183
      • 15. vendor/laravel/framework/src/Illuminate/Foundation/Http/Middleware/VerifyCsrfToken.php:88
    • INSERT INTO visitor_ip_address_detail (ip_address,visitor_url,visitor_count, created_on,updated_on) VALUES ('873336012','/article/110143',1,1740516230,1740516230)
      140μsalphaeurekaselec_live_10_06_2022UserAccessCheck.php#27
      Backtrace
      • 11. middleware::check_user_access:27
      • 12. vendor/laravel/framework/src/Illuminate/Pipeline/Pipeline.php:183
      • 13. vendor/laravel/framework/src/Illuminate/Routing/Middleware/SubstituteBindings.php:50
      • 14. vendor/laravel/framework/src/Illuminate/Pipeline/Pipeline.php:183
      • 15. vendor/laravel/framework/src/Illuminate/Foundation/Http/Middleware/VerifyCsrfToken.php:88
    • (select `user_id`, `to_ip`, `from_ip` from (select user_id, to_ip, from_ip FROM user_access_journal_volume_trail WHERE to_ip >= 873336012 ORDER BY to_ip ASC LIMIT 1) as `tjv` where `from_ip` <= 873336012) union (select `user_id`, `to_ip`, `from_ip` from (select user_id, to_ip, from_ip FROM user_access_journal_volume_corporate WHERE to_ip >= 873336012 ORDER BY to_ip ASC LIMIT 1) as `tjv` where `from_ip` <= 873336012) union (select `user_id`, `to_ip`, `from_ip` from (select user_id, to_ip, from_ip FROM user_access_journal_volume_token WHERE to_ip >= 873336012 ORDER BY to_ip ASC LIMIT 1) as `tjv` where `from_ip` <= 873336012) union (select `user_id`, `to_ip`, `from_ip` from (select user_id, to_ip, from_ip FROM user_access_ebook_volume_trail WHERE to_ip >= 873336012 ORDER BY to_ip ASC LIMIT 1) as `tjv` where `from_ip` <= 873336012) union (select `user_id`, `to_ip`, `from_ip` from (select user_id, to_ip, from_ip FROM user_access_ebook_volume_corporate WHERE to_ip >= 873336012 ORDER BY to_ip ASC LIMIT 1) as `tjv` where `from_ip` <= 873336012) union (select `user_id`, `to_ip`, `from_ip` from (select user_id, to_ip, from_ip FROM user_access_ebook_volume_token WHERE to_ip >= 873336012 ORDER BY to_ip ASC LIMIT 1) as `tjv` where `from_ip` <= 873336012) union (select `user_id`, `to_ip`, `from_ip` from (select user_id, to_ip, from_ip FROM user_access_issue_trail WHERE to_ip >= 873336012 ORDER BY to_ip ASC LIMIT 1) as `tjv` where `from_ip` <= 873336012) union (select `user_id`, `to_ip`, `from_ip` from (select user_id, to_ip, from_ip FROM user_access_issue_corporate WHERE to_ip >= 873336012 ORDER BY to_ip ASC LIMIT 1) as `tjv` where `from_ip` <= 873336012) union (select `user_id`, `to_ip`, `from_ip` from (select user_id, to_ip, from_ip FROM user_access_issue_token WHERE to_ip >= 873336012 ORDER BY to_ip ASC LIMIT 1) as `tjv` where `from_ip` <= 873336012) union (select `user_id`, `to_ip`, `from_ip` from (select user_id, to_ip, from_ip FROM user_access_article_trail WHERE to_ip >= 873336012 ORDER BY to_ip ASC LIMIT 1) as `tjv` where `from_ip` <= 873336012) union (select `user_id`, `to_ip`, `from_ip` from (select user_id, to_ip, from_ip FROM user_access_article_corporate WHERE to_ip >= 873336012 ORDER BY to_ip ASC LIMIT 1) as `tjv` where `from_ip` <= 873336012) union (select `user_id`, `to_ip`, `from_ip` from (select user_id, to_ip, from_ip FROM user_access_article_token WHERE to_ip >= 873336012 ORDER BY to_ip ASC LIMIT 1) as `tjv` where `from_ip` <= 873336012) union (select `user_id`, `to_ip`, `from_ip` from (select user_id, to_ip, from_ip FROM user_access_chapter_trail WHERE to_ip >= 873336012 ORDER BY to_ip ASC LIMIT 1) as `tjv` where `from_ip` <= 873336012) union (select `user_id`, `to_ip`, `from_ip` from (select user_id, to_ip, from_ip FROM user_access_chapter_corporate WHERE to_ip >= 873336012 ORDER BY to_ip ASC LIMIT 1) as `tjv` where `from_ip` <= 873336012) union (select `user_id`, `to_ip`, `from_ip` from (select user_id, to_ip, from_ip FROM user_access_chapter_token WHERE to_ip >= 873336012 ORDER BY to_ip ASC LIMIT 1) as `tjv` where `from_ip` <= 873336012) union (select `user_id`, `to_ip`, `from_ip` from (select user_id, to_ip, from_ip FROM user_access_disease_corporate WHERE to_ip >= 873336012 ORDER BY to_ip ASC LIMIT 1) as `tjv` where `from_ip` <= 873336012) limit 1
      12.51msalphaeurekaselec_live_10_06_2022UserAccess.php#784
      Bindings
      • 0: 873336012
      • 1: 873336012
      • 2: 873336012
      • 3: 873336012
      • 4: 873336012
      • 5: 873336012
      • 6: 873336012
      • 7: 873336012
      • 8: 873336012
      • 9: 873336012
      • 10: 873336012
      • 11: 873336012
      • 12: 873336012
      • 13: 873336012
      • 14: 873336012
      • 15: 873336012
      Backtrace
      • 14. app/Models/UserAccess/UserAccess.php:784
      • 15. middleware::check_user_access:114
      • 16. vendor/laravel/framework/src/Illuminate/Pipeline/Pipeline.php:183
      • 17. vendor/laravel/framework/src/Illuminate/Routing/Middleware/SubstituteBindings.php:50
      • 18. vendor/laravel/framework/src/Illuminate/Pipeline/Pipeline.php:183
    • SELECT at.type_name, p.copyright, p.publisher_location,m.month,y.year, a.publish_on, a.nid article_nid,a.article_id, a.pmid, a.issue_id, a.title, a.abstract,a.podcast,a.altmetric_score,a.altmetric_url,a.kudos_url, a.page_count, a.first_page, a.elocator, a.last_page, i.publication_date, a.file_name, a.file_path, a.doi, a.is_epub,a.epub_type, a.volume_id, a.is_uploaded, a.editor_choice, a.is_epub, j.image_file_name, a.article_no, a.art_type AS article_type, a.supplementary_filename,a.html_filename,a.prc_filename,a.epub_filename, a.graph_abs_lg_filename, a.graph_abs_sm_filename, a.oa_image_lg_filename, a.oa_image_sm_filename, j.journal_banner,a.animated_abstract,a.erratum_in,a.erratum_for, (CASE WHEN a.issue_id =0 THEN j.epub_price ELSE j.price END) AS sell_price, j.epub_price, j.nid AS jour_nid, j.title AS journal_title, j.issn, j.eissn,j.journal_id, j.subtitle AS jour_subtitle, v.volume_id,v.volume_name AS volume, v.year_id, i.title AS issue, i.month_id ,i.type issue_type, j.subtitle,j.formerly_title, ac.subtitle AS epub_title,a.crossmark_enabled,a.text_mining_urls,a.license_urls,a.created, a.receivedate, a.revisedate, a.acceptdate,js.js_title FROM article a LEFT JOIN article_section ac ON a.is_epub = ac.art_sec_id LEFT JOIN journal_section js ON a.js_id = js.js_id LEFT JOIN article_type at ON a.art_type = at.art_type_id LEFT JOIN issue i ON a.issue_id = i.issue_id LEFT JOIN month m ON m.id = i.month_id LEFT JOIN volume v ON v.volume_id = a.volume_id INNER JOIN year y ON y.id = v.year_id INNER JOIN journal j ON j.journal_id = a.journal_id INNER JOIN publisher p ON p.publisher_id = j.publisher_id WHERE a.article_id=110143
      1.46msalphaeurekaselec_live_10_06_2022Article.php#408
      Backtrace
      • 11. app/Models/Article.php:408
      • 12. app/Http/Controllers/ArticleController.php:2515
      • 13. app/Http/Controllers/ArticleController.php:2035
      • 14. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 15. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
    • select * from `journal` where `journal_id` = 38 limit 1
      820μsalphaeurekaselec_live_10_06_2022Journal.php#64
      Bindings
      • 0: 38
      Backtrace
      • 14. app/Models/Journal.php:64
      • 15. app/Http/Controllers/ArticleController.php:2516
      • 16. app/Http/Controllers/ArticleController.php:2035
      • 17. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 18. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
    • select count(*) as aggregate from (select j.nid as journal_nid,j.flyer_link,j.title ,j.issn,j.eissn,j.keyword, j.journal_id as journal_id, j.subtitle, j.image_file_name,j.description,j.journal_insight_url,j.doi from `subject_journal` as `sj` inner join `journal` as `j` on `j`.`journal_id` = `sj`.`journal_id` where j.journal_status=1 and subject_id IN (SELECT subject_id FROM subject_journal WHERE journal_id=38) and sj.journal_id!=38 group by `j`.`nid`) as `aggregate_table`
      1.24msalphaeurekaselec_live_10_06_2022Subject.php#200
      Backtrace
      • 16. app/Models/Subject.php:200
      • 17. app/Http/Controllers/ArticleController.php:2517
      • 18. app/Http/Controllers/ArticleController.php:2035
      • 19. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 20. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
    • select j.nid as journal_nid,j.flyer_link,j.title ,j.issn,j.eissn,j.keyword, j.journal_id as journal_id, j.subtitle, j.image_file_name,j.description,j.journal_insight_url,j.doi from `subject_journal` as `sj` inner join `journal` as `j` on `j`.`journal_id` = `sj`.`journal_id` where j.journal_status=1 and subject_id IN (SELECT subject_id FROM subject_journal WHERE journal_id=38) and sj.journal_id!=38 group by `j`.`nid` order by `j`.`journal_id` asc limit 10 offset 0
      980μsalphaeurekaselec_live_10_06_2022Subject.php#200
      Backtrace
      • 14. app/Models/Subject.php:200
      • 15. app/Http/Controllers/ArticleController.php:2517
      • 16. app/Http/Controllers/ArticleController.php:2035
      • 17. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 18. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
    • select count(*) as aggregate from (select v.nid as volume_id,e.nid,e.title,v.issn,v.eissn,v.isbn,v.eisbn,e.ebook_id, v.image_file_name,v.file_path,v.flyer_link,v.ebook_volume_id, v.volume_name,v.doi,v.year_id,v.introduction from `subject_ebook` as `se` inner join `ebook` as `e` on `e`.`ebook_id` = `se`.`ebook_id` inner join `ebook_volume` as `v` on `v`.`ebook_id` = `se`.`ebook_id` inner join `year` as `y` on `y`.`id` = `v`.`year_id` where subject_id IN (SELECT subject_id FROM subject_journal WHERE journal_id=38) and v.ebook_status='1' and y.year > 2020 group by `v`.`nid`) as `aggregate_table`
      51.99msalphaeurekaselec_live_10_06_2022Subject.php#220
      Backtrace
      • 16. app/Models/Subject.php:220
      • 17. app/Http/Controllers/ArticleController.php:2518
      • 18. app/Http/Controllers/ArticleController.php:2035
      • 19. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 20. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
    • select v.nid as volume_id,e.nid,e.title,v.issn,v.eissn,v.isbn,v.eisbn,e.ebook_id, v.image_file_name,v.file_path,v.flyer_link,v.ebook_volume_id, v.volume_name,v.doi,v.year_id,v.introduction from `subject_ebook` as `se` inner join `ebook` as `e` on `e`.`ebook_id` = `se`.`ebook_id` inner join `ebook_volume` as `v` on `v`.`ebook_id` = `se`.`ebook_id` inner join `year` as `y` on `y`.`id` = `v`.`year_id` where subject_id IN (SELECT subject_id FROM subject_journal WHERE journal_id=38) and v.ebook_status='1' and y.year > 2020 group by `v`.`nid` order by `v`.`ebook_volume_id` desc limit 10 offset 0
      7.43msalphaeurekaselec_live_10_06_2022Subject.php#220
      Backtrace
      • 14. app/Models/Subject.php:220
      • 15. app/Http/Controllers/ArticleController.php:2518
      • 16. app/Http/Controllers/ArticleController.php:2035
      • 17. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 18. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
    • select * from `keywords` where `article_id` = '110143'
      370μsalphaeurekaselec_live_10_06_2022Keywords.php#43
      Bindings
      • 0: 110143
      Backtrace
      • 13. app/Models/Keywords.php:43
      • 14. app/Http/Controllers/ArticleController.php:2519
      • 15. app/Http/Controllers/ArticleController.php:2035
      • 16. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 17. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
    • select * from `article_citation` where `article_id` = '110143'
      4.26msalphaeurekaselec_live_10_06_2022Article.php#1570
      Bindings
      • 0: 110143
      Backtrace
      • 13. app/Models/Article.php:1570
      • 14. app/Http/Controllers/ArticleController.php:2520
      • 15. app/Http/Controllers/ArticleController.php:2035
      • 16. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 17. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
    • select CONCAT_WS(' ',au.first_name, ' ', ifnull(au.initials,''), ' ', au.last_name) as authors, CONCAT(au.last_name, IFNULL(CONCAT(' ', au.initials), ''), ' ', au.first_name) AS authorsRIS, CONCAT_WS(' ',au.last_name, ' ', ifnull(au.initials,''), ' ', au.first_name) as authorsCiteAs, CONCAT_WS(' ',au.first_name, IFNULL(CONCAT(' ', au.initials), ''), IFNULL(CONCAT(' ', au.last_name), '')) as authorsmodal , `au`.*, `af`.`ror_id`, `af`.`institution`, `af`.`department`, `af`.`country`, `af`.`city`, `af`.`address`, (GROUP_CONCAT(TRIM(BOTH ', ' FROM CONCAT(ifnull(concat(af.institution,','),''), ifnull(concat(af.department,','),''), ifnull(concat(af.address,','),''), ifnull(concat(af.city,','),''), ifnull(concat(af.country,','),''), ifnull(concat(af.postal_code,','),''), ifnull(concat(af.phone,','),''), ifnull(concat(af.fax,','),''))) SEPARATOR '|')) as `author_affiliation`, (GROUP_CONCAT(TRIM(BOTH ', ' FROM CONCAT(ifnull(concat(af.web_view,','),''))) SEPARATOR '|')) as `web_view` from `author` as `au` left join `author_affiliation` as `af` on `au`.`author_id` = `af`.`author_id` where `au`.`article_id` = '110143' group by `au`.`author_id` order by `au`.`article_id` asc, `au`.`sequence` asc
      680μsalphaeurekaselec_live_10_06_2022Author.php#86
      Bindings
      • 0: 110143
      Backtrace
      • 13. app/Models/Author.php:86
      • 14. app/Http/Controllers/ArticleController.php:2533
      • 15. app/Http/Controllers/ArticleController.php:2035
      • 16. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 17. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
    • select `bo`.* from `bundle_offer` as `bo` where `bo`.`bundle_status` = 'A' order by `bo`.`bundle_id` desc
      220μsalphaeurekaselec_live_10_06_2022BundleOffer.php#57
      Bindings
      • 0: A
      Backtrace
      • 13. app/Models/BundleOffer.php:57
      • 14. app/Http/Controllers/ArticleController.php:2535
      • 15. app/Http/Controllers/ArticleController.php:2035
      • 16. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 17. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
    • select `subtitle` from `journal` where `continues_publication_journal` = 1
      440μsalphaeurekaselec_live_10_06_2022Article.php#1960
      Bindings
      • 0: 1
      Backtrace
      • 13. app/Models/Article.php:1960
      • 14. app/Http/Controllers/ArticleController.php:2062
      • 15. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 16. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
      • 17. vendor/laravel/framework/src/Illuminate/Routing/Route.php:260
    • Select j.subtitle, v.volume_id as volume_id,v.year_id,y.year as year,v.volume_name, v.total_no_of_issues, i.issue_id as issue_id,i.title as issue, i.publication_date as issue_pub_date from journal j join volume v on j.journal_id = v.journal_id join issue i on v.volume_id = i.volume_id join article a on a.issue_id = i.issue_id join year y on v.year_id = y.id where j.journal_id = 38 and i.is_uploaded = 1 order by v.volume_name+0 desc, i.title+0 desc limit 1
      91.55msalphaeurekaselec_live_10_06_2022Issue.php#298
      Backtrace
      • 11. app/Models/Issue.php:298
      • 12. app/Http/Controllers/ArticleController.php:2068
      • 13. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 14. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
      • 15. vendor/laravel/framework/src/Illuminate/Routing/Route.php:260
    • select a.nid,a.publish_on, a.pmid,a.article_id,a.doi,j.journal_id,j.subtitle,v.volume_name,a.volume_id as volume_id, a.issue_id,a.title,first_page, last_page, page_count,abstract,ifnull(is_abstract,"y"),asec.title as article_section,at.type_name as article_type_name, a.article_id as ArticleID ,is_epub,epub_price,epub_type,a.created, y.year from `article` as `a` left join `article_section` as `asec` on `asec`.`art_sec_id` = `a`.`is_epub` left join `article_type` as `at` on `at`.`art_type_id` = `a`.`art_type` left join `journal` as `j` on `j`.`journal_id` = `a`.`journal_id` inner join `volume` as `v` on `a`.`volume_id` = `v`.`volume_id` inner join `year` as `y` on `v`.`year_id` = `y`.`id` where a.article_status != "W" and a.is_epub = 1 and a.journal_id = 38 and a.is_uploaded = 1 group by `a`.`article_id` order by `a`.`publish_on` desc
      23.37msalphaeurekaselec_live_10_06_2022Article.php#528
      Backtrace
      • 13. app/Models/Article.php:528
      • 14. app/Http/Controllers/ArticleController.php:2070
      • 15. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 16. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
      • 17. vendor/laravel/framework/src/Illuminate/Routing/Route.php:260
    • select a.nid,a.publish_on, a.pmid,a.article_id,a.doi,j.journal_id,j.subtitle,v.volume_name,a.volume_id as volume_id, a.issue_id,a.title,first_page, last_page, page_count,abstract,ifnull(is_abstract,"y"),asec.title as article_section,at.type_name as article_type_name, a.article_id as ArticleID ,is_epub,epub_price,epub_type,a.created, y.year from `article` as `a` left join `article_section` as `asec` on `asec`.`art_sec_id` = `a`.`is_epub` left join `article_type` as `at` on `at`.`art_type_id` = `a`.`art_type` left join `journal` as `j` on `j`.`journal_id` = `a`.`journal_id` inner join `volume` as `v` on `a`.`volume_id` = `v`.`volume_id` inner join `year` as `y` on `v`.`year_id` = `y`.`id` where a.article_status != "W" and a.is_epub = 4 and a.journal_id = 38 and a.is_uploaded = 1 group by `a`.`article_id` order by `a`.`publish_on` desc
      17.88msalphaeurekaselec_live_10_06_2022Article.php#528
      Backtrace
      • 13. app/Models/Article.php:528
      • 14. app/Http/Controllers/ArticleController.php:2071
      • 15. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 16. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
      • 17. vendor/laravel/framework/src/Illuminate/Routing/Route.php:260
    • select pdf, html, epub, prc from `article_metrics` where `article_id` = 110143 limit 1
      220μsalphaeurekaselec_live_10_06_2022Article.php#744
      Bindings
      • 0: 110143
      Backtrace
      • 14. app/Models/Article.php:744
      • 15. app/Http/Controllers/ArticleController.php:2091
      • 16. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 17. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
      • 18. vendor/laravel/framework/src/Illuminate/Routing/Route.php:260
    • select * from content_by_diseases where content_id = 110143 and content_type = 'article' order by status desc limit 1
      220μsalphaeurekaselec_live_10_06_2022Article.php#751
      Backtrace
      • 11. app/Models/Article.php:751
      • 12. app/Http/Controllers/ArticleController.php:2094
      • 13. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 14. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
      • 15. vendor/laravel/framework/src/Illuminate/Routing/Route.php:260
    • select * from `node_meta` where `nid` = 186176 limit 1
      180μsalphaeurekaselec_live_10_06_2022Meta.php#30
      Bindings
      • 0: 186176
      Backtrace
      • 14. app/Models/Meta.php:30
      • 15. app/Http/Controllers/ArticleController.php:2101
      • 16. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 17. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
      • 18. vendor/laravel/framework/src/Illuminate/Routing/Route.php:260
    • select `bo`.* from `bundle_offer` as `bo` where `bo`.`bundle_status` = 'A' order by `bo`.`bundle_id` desc
      220μsalphaeurekaselec_live_10_06_2022BundleOffer.php#57
      Bindings
      • 0: A
      Backtrace
      • 13. app/Models/BundleOffer.php:57
      • 14. app/Http/Controllers/ArticleController.php:2108
      • 15. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 16. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
      • 17. vendor/laravel/framework/src/Illuminate/Routing/Route.php:260
    • select * from `tbl_ht_submission` as `h` where `h`.`subtitle` = 'CTMC' and (h.proposal_closing_date = 0 OR TO_DAYS(FROM_UNIXTIME(h.proposal_closing_date)) >= TO_DAYS(NOW())) order by `h`.`manuscript` asc
      360μsalphaeurekaselec_live_10_06_2022Article.php#2025
      Bindings
      • 0: CTMC
      Backtrace
      • 13. app/Models/Article.php:2025
      • 14. app/Http/Controllers/ArticleController.php:2112
      • 15. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 16. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
      • 17. vendor/laravel/framework/src/Illuminate/Routing/Route.php:260
    • select count(*) as total_count, content_type_access_id as access_type from journal_access where content_type_id = '110143' and content_type = 'a' and ( (from_date <= CURDATE() and to_date >= CURDATE() and perpetual= 0) or (from_date is null and to_date is null and perpetual= 1) )
      360μsalphaeurekaselec_live_10_06_2022ContentAccess.php#647
      Backtrace
      • 11. app/Models/ContentAccess.php:647
      • 12. app/Http/Controllers/ArticleController.php:2186
      • 13. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 14. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
      • 15. vendor/laravel/framework/src/Illuminate/Routing/Route.php:260
    • select count(*) as total_count, content_type_access_id as access_type from journal_access where content_type_id = '10283' and content_type = 'i' and ( (from_date <= CURDATE() and to_date >= CURDATE() and perpetual= 0) or (from_date is null and to_date is null and perpetual= 1) )
      290μsalphaeurekaselec_live_10_06_2022ContentAccess.php#647
      Backtrace
      • 11. app/Models/ContentAccess.php:647
      • 12. app/Http/Controllers/ArticleController.php:2207
      • 13. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 14. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
      • 15. vendor/laravel/framework/src/Illuminate/Routing/Route.php:260
    • select count(*) as total_count, content_type_access_id as access_type from journal_access where content_type_id = '2932' and content_type = 'v' and ( (from_date <= CURDATE() and to_date >= CURDATE() and perpetual= 0) or (from_date is null and to_date is null and perpetual= 1) )
      250μsalphaeurekaselec_live_10_06_2022ContentAccess.php#647
      Backtrace
      • 11. app/Models/ContentAccess.php:647
      • 12. app/Http/Controllers/ArticleController.php:2231
      • 13. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 14. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
      • 15. vendor/laravel/framework/src/Illuminate/Routing/Route.php:260
    • (select j.user_access_id,j.volume_id,j.user_id,j.from_ip,j.to_ip,j.type,j.track,"Trial Access" as access_base_text, CASE j.type WHEN 111 THEN true ELSE false END as terms_popup, "S" as content_download_type, null as restricted_user_access_key, null as restricted_user_access_type, CASE j.track WHEN 0 THEN false ELSE true END as tracksAccessByVolume,"volume" as access_level,"" as issue_id,"" as article_id from `user_access_journal_volume_trail` as `j` inner join `user_access_info` as `info` on `j`.`user_access_id` = `info`.`user_access_id` where ((j.from_ip <= 873336012 and j.to_ip >=873336012 )) and ((j.from_date <= 1740516231 and j.to_date >= 1740516231 and j.perpetual= 0) or (j.from_date is null and j.to_date is null and j.perpetual= 1)) and j.volume_id = 2932) union (select j.user_access_id,j.volume_id,j.user_id,j.from_ip,j.to_ip,j.type,j.track,"Subscribed" as access_base_text, false as terms_popup, "S" as content_download_type, null as restricted_user_access_key, null as restricted_user_access_type, CASE j.track WHEN 0 THEN false ELSE true END as tracksAccessByVolume,"volume" as access_level,"" as issue_id,"" as article_id from `user_access_journal_volume_corporate` as `j` inner join `user_access_info` as `info` on `j`.`user_access_id` = `info`.`user_access_id` where ((j.from_ip <= 873336012 and j.to_ip >=873336012 )) and ((j.from_date <= 1740516231 and j.to_date >= 1740516231 and j.perpetual= 0) or (j.from_date is null and j.to_date is null and j.perpetual= 1)) and j.volume_id = 2932) union (select j.user_access_id,j.volume_id,j.user_id,j.from_ip,j.to_ip,j.type,j.track,"Token Based Access" as access_base_text, false as terms_popup, "R" as content_download_type, j.uc_id as restricted_user_access_key, "v" as restricted_user_access_type, CASE j.track WHEN 0 THEN false ELSE true END as tracksAccessByVolume,"volume" as access_level,"" as issue_id,"" as article_id from `user_access_journal_volume_token` as `j` inner join `user_access_info` as `info` on `j`.`user_access_id` = `info`.`user_access_id` where ((j.from_ip <= 873336012 and j.to_ip >=873336012 )) and ((j.from_date <= 1740516231 and j.to_date >= 1740516231 and j.perpetual= 0) or (j.from_date is null and j.to_date is null and j.perpetual= 1)) and j.volume_id = 2932)
      10.9msalphaeurekaselec_live_10_06_2022UserAccess.php#1266
      Backtrace
      • 13. app/Models/UserAccess/UserAccess.php:1266
      • 14. app/Http/Controllers/ArticleController.php:2272
      • 15. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 16. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
      • 17. vendor/laravel/framework/src/Illuminate/Routing/Route.php:260
    • (select j.user_access_id,j.volume_id,j.user_id,j.from_ip,j.to_ip,j.type,j.track,"Trial Access" as access_base_text, CASE j.type WHEN 111 THEN true ELSE false END as terms_popup, "S" as content_download_type, null as restricted_user_access_key, null as restricted_user_access_type, CASE j.track WHEN 0 THEN false ELSE true END as tracksAccessByVolume,"issue" as access_level,j.issue_id,"" as article_id from `user_access_issue_trail` as `j` inner join `user_access_info` as `info` on `j`.`user_access_id` = `info`.`user_access_id` where ((j.from_ip <= 873336012 and j.to_ip >=873336012 )) and ((j.from_date <= 1740516231 and j.to_date >= 1740516231 and j.perpetual= 0) or (j.from_date is null and j.to_date is null and j.perpetual= 1)) and j.issue_id = 10283) union (select j.user_access_id,j.volume_id,j.user_id,j.from_ip,j.to_ip,j.type,j.track,"Subscribed" as access_base_text, false as terms_popup, "S" as content_download_type, null as restricted_user_access_key, null as restricted_user_access_type, CASE j.track WHEN 0 THEN false ELSE true END as tracksAccessByVolume,"issue" as access_level,j.issue_id,"" as article_id from `user_access_issue_corporate` as `j` inner join `user_access_info` as `info` on `j`.`user_access_id` = `info`.`user_access_id` where ((j.from_ip <= 873336012 and j.to_ip >=873336012 )) and ((j.from_date <= 1740516231 and j.to_date >= 1740516231 and j.perpetual= 0) or (j.from_date is null and j.to_date is null and j.perpetual= 1)) and j.issue_id = 10283) union (select j.user_access_id,j.volume_id,j.user_id,j.from_ip,j.to_ip,j.type,j.track,"Token Based Access" as access_base_text, false as terms_popup, "R" as content_download_type, j.uc_id as restricted_user_access_key, "v" as restricted_user_access_type, CASE j.track WHEN 0 THEN false ELSE true END as tracksAccessByVolume,"issue" as access_level,j.issue_id,"" as article_id from `user_access_issue_token` as `j` inner join `user_access_info` as `info` on `j`.`user_access_id` = `info`.`user_access_id` where ((j.from_ip <= 873336012 and j.to_ip >=873336012 )) and ((j.from_date <= 1740516231 and j.to_date >= 1740516231 and j.perpetual= 0) or (j.from_date is null and j.to_date is null and j.perpetual= 1)) and j.issue_id = 10283)
      580μsalphaeurekaselec_live_10_06_2022UserAccess.php#1266
      Backtrace
      • 13. app/Models/UserAccess/UserAccess.php:1266
      • 14. app/Http/Controllers/ArticleController.php:2297
      • 15. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 16. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
      • 17. vendor/laravel/framework/src/Illuminate/Routing/Route.php:260
    • (select j.user_access_id,j.volume_id,j.user_id,j.from_ip,j.to_ip,j.type,j.track,"Trial Access" as access_base_text, CASE j.type WHEN 111 THEN true ELSE false END as terms_popup, "S" as content_download_type, null as restricted_user_access_key, null as restricted_user_access_type, CASE j.track WHEN 0 THEN false ELSE true END as tracksAccessByVolume,"article" as access_level, j.issue_id, j.article_id from `user_access_article_trail` as `j` inner join `user_access_info` as `info` on `j`.`user_access_id` = `info`.`user_access_id` where ((j.from_ip <= 873336012 and j.to_ip >=873336012 )) and ((j.from_date <= 1740516231 and j.to_date >= 1740516231 and j.perpetual= 0) or (j.from_date is null and j.to_date is null and j.perpetual= 1)) and j.article_id = 110143) union (select j.user_access_id,j.volume_id,j.user_id,j.from_ip,j.to_ip,j.type,j.track,"Subscribed" as access_base_text, false as terms_popup, "S" as content_download_type, null as restricted_user_access_key, null as restricted_user_access_type, CASE j.track WHEN 0 THEN false ELSE true END as tracksAccessByVolume,"article" as access_level, j.issue_id, j.article_id from `user_access_article_corporate` as `j` inner join `user_access_info` as `info` on `j`.`user_access_id` = `info`.`user_access_id` where ((j.from_ip <= 873336012 and j.to_ip >=873336012 )) and ((j.from_date <= 1740516231 and j.to_date >= 1740516231 and j.perpetual= 0) or (j.from_date is null and j.to_date is null and j.perpetual= 1)) and j.article_id = 110143) union (select j.user_access_id,j.volume_id,j.user_id,j.from_ip,j.to_ip,j.type,j.track,"Token Based Access" as access_base_text, false as terms_popup, "R" as content_download_type, j.uc_id as restricted_user_access_key, "v" as restricted_user_access_type, CASE j.track WHEN 0 THEN false ELSE true END as tracksAccessByVolume,"article" as access_level, j.issue_id, j.article_id from `user_access_article_token` as `j` inner join `user_access_info` as `info` on `j`.`user_access_id` = `info`.`user_access_id` where ((j.from_ip <= 873336012 and j.to_ip >=873336012 )) and ((j.from_date <= 1740516231 and j.to_date >= 1740516231 and j.perpetual= 0) or (j.from_date is null and j.to_date is null and j.perpetual= 1)) and j.article_id = 110143)
      560μsalphaeurekaselec_live_10_06_2022UserAccess.php#1266
      Backtrace
      • 13. app/Models/UserAccess/UserAccess.php:1266
      • 14. app/Http/Controllers/ArticleController.php:2329
      • 15. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 16. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
      • 17. vendor/laravel/framework/src/Illuminate/Routing/Route.php:260
    • select * from `article` where `first_page` < '126' and is_uploaded = 1 and issue_id = 10283 order by cast(first_page as SIGNED) desc limit 1
      440μsalphaeurekaselec_live_10_06_2022Article.php#1819
      Bindings
      • 0: 126
      Backtrace
      • 14. app/Models/Article.php:1819
      • 15. app/Http/Controllers/ArticleController.php:2470
      • 16. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 17. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
      • 18. vendor/laravel/framework/src/Illuminate/Routing/Route.php:260
    • select * from `article` where `last_page` > '139' and is_uploaded = 1 and issue_id = 10283 order by cast(first_page as SIGNED) asc limit 1
      380μsalphaeurekaselec_live_10_06_2022Article.php#1831
      Bindings
      • 0: 139
      Backtrace
      • 14. app/Models/Article.php:1831
      • 15. app/Http/Controllers/ArticleController.php:2472
      • 16. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 17. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
      • 18. vendor/laravel/framework/src/Illuminate/Routing/Route.php:260
    • select `language_id` from `multilanguage` where `short_code` = 'en'
      170μsalphaeurekaselec_live_10_06_2022ArticleController.php#2497
      Bindings
      • 0: en
      Backtrace
      • 14. app/Http/Controllers/ArticleController.php:2497
      • 15. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 16. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
      • 17. vendor/laravel/framework/src/Illuminate/Routing/Route.php:260
      • 18. vendor/laravel/framework/src/Illuminate/Routing/Route.php:206
    • select `source_lang_label`, `target_lang_label` from `multilanguage_labels` where `target_lang_id` = 1
      190μsalphaeurekaselec_live_10_06_2022MultiLanguage.php#23
      Bindings
      • 0: 1
      Backtrace
      • 13. app/Models/MultiLanguage.php:23
      • 14. app/Http/Controllers/ArticleController.php:2498
      • 15. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 16. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
      • 17. vendor/laravel/framework/src/Illuminate/Routing/Route.php:260
    • select `id` from `multilanguage_article` where `article_id` = 110143 limit 1
      2.32msalphaeurekaselec_live_10_06_2022ArticleController.php#2506
      Bindings
      • 0: 110143
      Backtrace
      • 16. app/Http/Controllers/ArticleController.php:2506
      • 17. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 18. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
      • 19. vendor/laravel/framework/src/Illuminate/Routing/Route.php:260
      • 20. vendor/laravel/framework/src/Illuminate/Routing/Route.php:206
    • select b.banner_link, b.banner_name, b.banner_script, b.banner_remarks, b.banner_file_name, b.banner_placement, bd.content_type, bd.content_id from `tbl_banner` as `b` inner join `tbl_banner_detail` as `bd` on `bd`.`banner_id` = `b`.`banner_id` inner join `users` as `u` on `u`.`id` = `b`.`updated_by` inner join `journal` as `j` on `j`.`journal_id` = `bd`.`content_id` where `b`.`banner_journal` = 1 and `bd`.`content_type` = 'J' and `bd`.`content_id` = 38 and `b`.`banner_from_date` <= 1740516231 and `b`.`banner_to_date` >= 1740516231 and `b`.`banner_status` = 'A' order by `b`.`banner_id` desc
      1.1msalphaeurekaselec_live_10_06_2022Banner.php#95
      Bindings
      • 0: 1
      • 1: J
      • 2: 38
      • 3: 1740516231
      • 4: 1740516231
      • 5: A
      Backtrace
      • 13. app/Models/Banner.php:95
      • 14. app/Http/helpers.php:404
      • 17. vendor/laravel/framework/src/Illuminate/Filesystem/Filesystem.php:124
      • 18. vendor/laravel/framework/src/Illuminate/View/Engines/PhpEngine.php:58
      • 19. vendor/laravel/framework/src/Illuminate/View/Engines/CompilerEngine.php:73
    • select b.banner_link, b.banner_name, b.banner_script, b.banner_remarks, b.banner_file_name, b.banner_placement, bd.content_type, bd.content_id from `tbl_banner` as `b` inner join `tbl_banner_detail` as `bd` on `bd`.`banner_id` = `b`.`banner_id` inner join `users` as `u` on `u`.`id` = `b`.`updated_by` inner join `journal` as `j` on `j`.`journal_id` = `bd`.`content_id` where `b`.`banner_journal` = 1 and `bd`.`content_type` = 'J' and `bd`.`content_id` = 38 and `b`.`banner_from_date` <= 1740516231 and `b`.`banner_to_date` >= 1740516231 and `b`.`banner_status` = 'A' order by `b`.`banner_id` desc
      1.04msalphaeurekaselec_live_10_06_2022Banner.php#95
      Bindings
      • 0: 1
      • 1: J
      • 2: 38
      • 3: 1740516231
      • 4: 1740516231
      • 5: A
      Backtrace
      • 13. app/Models/Banner.php:95
      • 14. app/Http/helpers.php:404
      • 17. vendor/laravel/framework/src/Illuminate/Filesystem/Filesystem.php:124
      • 18. vendor/laravel/framework/src/Illuminate/View/Engines/PhpEngine.php:58
      • 19. vendor/laravel/framework/src/Illuminate/View/Engines/CompilerEngine.php:73
    • select count(*) as aggregate from `uc_cart_products` where cart_id='7d640c4115dc84f6a05be4f013efc9c7'
      200μsalphaeurekaselec_live_10_06_2022Cart.php#271
      Backtrace
      • 15. app/Models/Cart.php:271
      • 16. view::layouts._header:260
      • 18. vendor/laravel/framework/src/Illuminate/Filesystem/Filesystem.php:124
      • 19. vendor/laravel/framework/src/Illuminate/View/Engines/PhpEngine.php:58
      • 20. vendor/laravel/framework/src/Illuminate/View/Engines/CompilerEngine.php:73
    App\Models\MultiLanguage
    1MultiLanguage.php#?
        _token
        tXfQ8AgAnQzLwh2B2zWY1NwtLFvvLORZcaMdhO6J
        uc_cart_id
        7d640c4115dc84f6a05be4f013efc9c7
        _previous
        array:1 [ "url" => "http://alpha.eurekaselect.com/article/110143" ]
        _flash
        array:2 [ "old" => [] "new" => [] ]
        PHPDEBUGBAR_STACK_DATA
        []
        path_info
        /article/110143
        status_code
        200
        
        status_text
        OK
        format
        html
        content_type
        text/html; charset=UTF-8
        request_query
        []
        
        request_request
        []
        
        request_headers
        0 of 0
        array:9 [ "cookie" => array:1 [ 0 => "wayfindertarget=eyJpdiI6InFQSGRQU1BEMXo1M1NtSk1Sa2ZwOGc9PSIsInZhbHVlIjoiUWtoTmx2Tll3RitKNExKUGVxdnBaZjlPSWpQNTBJZGI2QVdRNnZFbTZyTT0iLCJtYWMiOiJmMDkzMmY5YzdiNmYxOTVkYTQyODk0ZTdiYzkyMzcwOTMwOTFjZDMxOTUyNWVmOGEyZTg0OGFiMmJhNGViNTMwIiwidGFnIjoiIn0%3Dwayfindertarget=eyJpdiI6InFQSGRQU1BEMXo1M1NtSk1Sa2ZwOGc9PSIsInZhbHVlIjoiUWtoTmx2Tll3RitKNExKUGVxdnBaZjlPSWpQNTBJZGI2QVdRNnZFbTZyTT0iLCJtYWMiOiJmMDkzMmY5YzdiNmYx" ] "accept-encoding" => array:1 [ 0 => "gzip, deflate" ] "accept" => array:1 [ 0 => "text/html,application/xhtml+xml,application/xml;q=0.9,image/avif,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3;q=0.7" ] "user-agent" => array:1 [ 0 => "Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)" ] "upgrade-insecure-requests" => array:1 [ 0 => "1" ] "cache-control" => array:1 [ 0 => "no-cache" ] "pragma" => array:1 [ 0 => "no-cache" ] "connection" => array:1 [ 0 => "keep-alive" ] "host" => array:1 [ 0 => "alpha.eurekaselect.com" ] ]
        request_cookies
        0 of 0
        array:1 [ "wayfindertarget" => null ]
        response_headers
        0 of 0
        array:5 [ "content-type" => array:1 [ 0 => "text/html; charset=UTF-8" ] "cache-control" => array:1 [ 0 => "no-cache, private" ] "date" => array:1 [ 0 => "Tue, 25 Feb 2025 20:43:51 GMT" ] "set-cookie" => array:2 [ 0 => "XSRF-TOKEN=eyJpdiI6Ik93b3FIWUhibUwvUjJ1M1NkSFJXaGc9PSIsInZhbHVlIjoiYnczVEpjRXpXYmU2ZEdlTW9LWXlodTJuZ0JnVDM2Ym9wcDc4WklMbXF2NXhXSVBkWTg2MkV1aHZ5T29Vd0dpZ1g0ck5DalhSOURHcUZTY1dXNFRmYVMyWHNZSWhiVnB5MmhUNHFJTzJuZzhlZk9SdVIramdBOFJQellwTEtjYU0iLCJtYWMiOiIwN2JiNGUzNTcwNTVjMGFjZGI4Yzk4NDBhZWUwZGQ4ZWI5MTI1OTYxODE5OTM0NGE4YzMyODcwNjVlZDI0MjcxIiwidGFnIjoiIn0%3D; expires=Fri, 28 Feb 2025 08:43:51 GMT; Max-Age=216000; path=/; secure; samesite=laxXSRF-TOKEN=eyJpdiI6Ik93b3FIWUhibUwvUjJ1M1NkSFJXaGc9PSIsInZhbHVlIjoiYnczVEpjRXpXYmU2ZEdlTW9LWXlodTJuZ0JnVDM2Ym9wcDc4WklMbXF2NXhXSVBkWTg2MkV1aHZ5T29Vd0dpZ1g0ck5Da" 1 => "alphaeurekaselectnet_session=eyJpdiI6Iis4MWRacTYxeHBCYUV3WHBvYkVFQlE9PSIsInZhbHVlIjoiTThVUmI3NHJzZjdNUVdMRnI1TXFwUUhNK2ZVSXN2c1I3VGNtOVYyYmhyL2ErR3plVmlJa205ajg2cVBNaWhZRkJTSzhKM2psd1BoYTEwTEd5aGo1VythQWZsYUhBcXF2ZVEzeDluMUF0bVk2WjFZRDhSM21xTUNxOGNuK2g2SnEiLCJtYWMiOiIyM2Q3MGVmYTE1NzVlYjJkNDBhMTFkNjk3MmQ0MzIyMzlkMjE4YTIyNGQwODgwNzY2YzdkZjY3NjM2MDkxYTQxIiwidGFnIjoiIn0%3D; path=/; secure; httponly; samesite=laxalphaeurekaselectnet_session=eyJpdiI6Iis4MWRacTYxeHBCYUV3WHBvYkVFQlE9PSIsInZhbHVlIjoiTThVUmI3NHJzZjdNUVdMRnI1TXFwUUhNK2ZVSXN2c1I3VGNtOVYyYmhyL2ErR3plVmlJa205ajg" ] "Set-Cookie" => array:2 [ 0 => "XSRF-TOKEN=eyJpdiI6Ik93b3FIWUhibUwvUjJ1M1NkSFJXaGc9PSIsInZhbHVlIjoiYnczVEpjRXpXYmU2ZEdlTW9LWXlodTJuZ0JnVDM2Ym9wcDc4WklMbXF2NXhXSVBkWTg2MkV1aHZ5T29Vd0dpZ1g0ck5DalhSOURHcUZTY1dXNFRmYVMyWHNZSWhiVnB5MmhUNHFJTzJuZzhlZk9SdVIramdBOFJQellwTEtjYU0iLCJtYWMiOiIwN2JiNGUzNTcwNTVjMGFjZGI4Yzk4NDBhZWUwZGQ4ZWI5MTI1OTYxODE5OTM0NGE4YzMyODcwNjVlZDI0MjcxIiwidGFnIjoiIn0%3D; expires=Fri, 28-Feb-2025 08:43:51 GMT; path=/; secureXSRF-TOKEN=eyJpdiI6Ik93b3FIWUhibUwvUjJ1M1NkSFJXaGc9PSIsInZhbHVlIjoiYnczVEpjRXpXYmU2ZEdlTW9LWXlodTJuZ0JnVDM2Ym9wcDc4WklMbXF2NXhXSVBkWTg2MkV1aHZ5T29Vd0dpZ1g0ck5Da" 1 => "alphaeurekaselectnet_session=eyJpdiI6Iis4MWRacTYxeHBCYUV3WHBvYkVFQlE9PSIsInZhbHVlIjoiTThVUmI3NHJzZjdNUVdMRnI1TXFwUUhNK2ZVSXN2c1I3VGNtOVYyYmhyL2ErR3plVmlJa205ajg2cVBNaWhZRkJTSzhKM2psd1BoYTEwTEd5aGo1VythQWZsYUhBcXF2ZVEzeDluMUF0bVk2WjFZRDhSM21xTUNxOGNuK2g2SnEiLCJtYWMiOiIyM2Q3MGVmYTE1NzVlYjJkNDBhMTFkNjk3MmQ0MzIyMzlkMjE4YTIyNGQwODgwNzY2YzdkZjY3NjM2MDkxYTQxIiwidGFnIjoiIn0%3D; path=/; secure; httponlyalphaeurekaselectnet_session=eyJpdiI6Iis4MWRacTYxeHBCYUV3WHBvYkVFQlE9PSIsInZhbHVlIjoiTThVUmI3NHJzZjdNUVdMRnI1TXFwUUhNK2ZVSXN2c1I3VGNtOVYyYmhyL2ErR3plVmlJa205ajg" ] ]
        session_attributes
        0 of 0
        array:5 [ "_token" => "tXfQ8AgAnQzLwh2B2zWY1NwtLFvvLORZcaMdhO6J" "uc_cart_id" => "7d640c4115dc84f6a05be4f013efc9c7" "_previous" => array:1 [ "url" => "http://alpha.eurekaselect.com/article/110143" ] "_flash" => array:2 [ "old" => [] "new" => [] ] "PHPDEBUGBAR_STACK_DATA" => [] ]
        ClearShow all
        Date ↕MethodURLData
        #12025-02-25 20:43:51GET/article/110143414361